Research Topic: antifungal immunity

Role of Candida species in pathogenesis, immune regulation, and prognostic tools for managing ulcerative colitis and Crohn’s disease

mycolabadmin

This article explores how fungi, particularly Candida species, contribute to inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. The fungal microbiota becomes imbalanced in IBD patients, triggering harmful immune responses and worsening inflammation. The researchers propose that measuring specific Candida levels could help doctors diagnose disease severity and predict treatment response, opening new possibilities for personalized IBD management.

Read More »

BTK drives neutrophil activation for sterilizing antifungal immunity

mycolabadmin

BTK is a protein that helps neutrophils (immune cells) fight fungal infections, particularly Aspergillus fumigatus. A cancer drug called ibrutinib blocks BTK, which weakens neutrophil antifungal responses and increases the risk of serious fungal infections. The study found that GM-CSF may help restore some immune function in patients taking BTK-blocking drugs, offering a potential strategy to prevent these dangerous infections.

Read More »

PTP1B deficiency in myeloid cells increases susceptibility to Candida albicans systemic infection by modulating antifungal immunity

mycolabadmin

This research shows that a protein called PTP1B plays an important role in protecting the body against dangerous fungal infections caused by Candida albicans. When mice lacked this protein in their immune cells, they were much more susceptible to the infection and showed severe illness. The study found that PTP1B helps immune cells like macrophages and neutrophils fight the fungus effectively, and blocking this protein could actually make fungal infections worse.

Read More »
Scroll to Top